Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 10, 2009, Pages 1622-1630

  Apostolov, Eugene O ^a   Shah, Sudhir V ^a,b   Ray, Debarti ^a   Basnakian, Alexei G ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Atherosclerosis; Carbamylated LDL; Endothelial cells; LOX 1; Scavenger receptor

Indexed keywords

CARBAMYLATED LOW DENSITY LIPOPROTEIN; CD36 RECEPTOR; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1 RECEPTOR; PROTEIN ANTIBODY; SCAVENGER RECEPTOR; SR A1 RECEPTOR; SREC 1 RECEPTOR; UNCLASSIFIED DRUG; CARBAMYL LDL; CARBAMYL-LDL; CD36 ANTIGEN; OLR1 PROTEIN, HUMAN; OLR1 PROTEIN, MOUSE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCARF1 PROTEIN, HUMAN; SCAVENGER RECEPTOR F;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CARBAMOYLATION; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR BINDING; TRANSCYTOSIS; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CELL CULTURE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; MONOCYTES; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS E; SCAVENGER RECEPTORS, CLASS F;

EID: 70349580760     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.189795     Document Type: Article

References (28)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
2. Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl. 2001;78:S102-S107.
3. Apostolov EO, Shah SV, Ok E, Basnakian AG. Quantification of car-bamylated LDL in human sera by a new sandwich ELISA. Clin Chem. 2005;51:719-728.
4. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007; 13:1176-1184.
5. Apostolov EO, Basnakian AG, Yin X, Ok E, Shah SV. Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. Am J Physiol Heart Circ Physiol. 2007;292: H1836-H1846.
6. Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 2005;68: 173-178.
7. Apostolov EO, Shah SV, Ok E, Basnakian AG. Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2007;27:826-832.
8. Horkko S, Huttunen K, Kervinen K, Kesaniemi YA. Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein. Eur J Clin Invest. 1994;24:105-113. (Pubitemid 24222972)
9. Gonen B, Goldberg AP, Harter HR, Schonfeld G. Abnormal cell-interactive properties of low-density lipoproteins isolated from patients with chronic renal failure. Metabolism. 1985;34:10-14.
10. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Horkko S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V, Witztum JL. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci. 947:214-222, 2001; discussion 222-1213
11. Kesaniemi YA, Witztum JL, Steinbrecher UP. Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glu-cosylated low density lipoprotein. J Clin Invest. 1983;71:950-959.
12. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;63:601-637.
13. Wehr H, Mirkiewicz E, Rodo M, Bednarska-Makaruk M. Uptake of acetaldehyde-modified (ethylated) low-density lipoproteins by mouse peritoneal macrophages. Alcohol. 2002;26:163-166.
14. Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol. 2000; 20:1116-1122.
15. Allavena P, Del Maschio A. Leukocyte transmigration through vascular endothelium. An in vitro method. Methods Mol Biol. 1999;96:171-176.
16. Heinloth A, Heermeier K, Raff U, Wanner C, Galle J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J Am Soc Nephrol. 2000;11: 1819-1825.
17. Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA. Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int. 1992;41:1175-1181.
18. Mehrabi MR, Sinzinger H, Ekmekcioglu C, Tamaddon F, Plesch K, Glogar HD, Maurer G, Stefenelli T, Lang IM. Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis. Cardiovasc Res. 2000;45:874-882.
19. Smirnova IV, Sawamura T, Goligorsky MS. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency. Am J Physiol Renal Physiol. 2004;287: F25-F32.
20. Daviet L, Malvoisin E, Wild TF, McGregor JL. Thrombospondin induces dimerization of membrane-bound, but not soluble CD36. Thromb Haemost. 1997;78:897-901.
21. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000; 101:2889-2895.
22. Kume N, Kita T. Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture. Circ Res. 2004;94:269-270.
23. Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyo-cardial vasculopathy in apolipoprotein E-null mice. Circ Res. 2005;97: 176-184.
24. Stewart BW, Nagarajan S. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion. Mol Immunol. 2006;43: 255-267.
25. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
26. Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois MG, Febbraio M, Silverstein RL, Tremblay A, Ong H. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J. 2005; 19:1869-1871.
27. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104: 503-516.
28. Inoue N, Sawamura T. Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases. Methods. 2007;43:218-222.